NCT04334408 Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL Status WITHDRAWN Phase PHASE2
NCT04299958 Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study Status COMPLETED Phase N/A
NCT04294147 A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist Status COMPLETED Phase PHASE4
NCT04281030 Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department Status COMPLETED Phase NA
NCT04276142 Effectiveness of a Dialogue-based Online Intervention Against Migraine Status COMPLETED Phase NA
NCT04265755 Biomarker and Genetic Predictors of Erenumab Treatment Response Status COMPLETED Phase PHASE4
NCT04260035 The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients Status COMPLETED Phase NA
NCT04252742 Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine Status COMPLETED Phase PHASE4
NCT04252521 Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine Status COMPLETED Phase NA
NCT04219345 Transcranial Direct Current Stimulation Associated With Mindfulness in Chronic Migraine Status UNKNOWN Phase NA
NCT04211454 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches Status WITHDRAWN Phase N/A
NCT04197349 Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Status COMPLETED Phase PHASE1
NCT04196933 Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma Status WITHDRAWN Phase NA
NCT04179474 Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Status COMPLETED Phase PHASE1
NCT04171362 The Effect of Connective Tissue Massage in Patients With Migraine Status COMPLETED Phase NA
NCT04163185 Initiating Early Control of Migraine Pain and Associated Symptoms Status COMPLETED Phase PHASE3
NCT04152083 A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine Status COMPLETED Phase PHASE3
NCT04138316 CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study Status COMPLETED Phase N/A